PubRank

Jeremy Sugarman

Author PubWeight™ 180.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth 2004 14.06
2 Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioeth 2008 5.73
3 Dealing with the long-term social implications of research. Am J Bioeth 2011 5.41
4 Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol 2008 5.24
5 Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg 2010 5.05
6 Medical and nursing students' television viewing habits: potential implications for bioethics. Am J Bioeth 2008 4.94
7 A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 2002 4.42
8 Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med 2004 3.58
9 Ethical goals of community consultation in research. Am J Public Health 2005 3.46
10 The cost of institutional review boards in academic medical centers. N Engl J Med 2005 3.06
11 Bioethics consultation in the private sector. Hastings Cent Rep 2002 3.01
12 The inescapable relevance of bioethics for the practicing clinician. Chest 2006 2.70
13 New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008 2.61
14 Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med 2003 2.56
15 Ethical considerations for short-term experiences by trainees in global health. JAMA 2008 2.48
16 The Presidential Bioethics Commission's database of human subjects research. IRB 2013 1.98
17 Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings? Clin Infect Dis 2013 1.92
18 Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum 2003 1.86
19 The OHRP and SUPPORT. N Engl J Med 2013 1.78
20 Ethics in human subjects research: do incentives matter? J Med Philos 2004 1.70
21 Measuring trust in medical researchers. Med Care 2006 1.69
22 Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol 2002 1.64
23 What patients say about medical research. IRB 1999 1.63
24 Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med 2006 1.63
25 Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med 2005 1.62
26 Back to the rough ground: working in international HIV prevention as ethical debates continue. IRB 2003 1.62
27 Permission and assent for clinical research in pediatric anesthesia. Anesth Analg 2002 1.56
28 Ethical and practical issues associated with aggregating databases. PLoS Med 2008 1.53
29 Community hospital oversight of clinical investigators' financial relationships. IRB 2009 1.51
30 Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research. Circ Cardiovasc Qual Outcomes 2010 1.50
31 Applying justice in clinical trials for diverse populations. Clin Trials 2007 1.46
32 Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med 2006 1.43
33 Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest 2005 1.43
34 Implications of universal screening for HIV infection. BMJ 2013 1.37
35 The Bio-PIN: a concept to improve biobanking. Nat Rev Cancer 2011 1.32
36 Beyond "compliance": the role of institutional culture in promoting research integrity. Acad Med 2010 1.30
37 Preventive misconception: its nature, presence, and ethical implications for research. Am J Prev Med 2007 1.30
38 Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey. Fertil Steril 2008 1.30
39 Regulatory challenges for the resuscitation outcomes consortium. Circulation 2008 1.26
40 Variability in the costs of institutional review board oversight. Acad Med 2006 1.25
41 Toward protecting the safety of participants in clinical trials. Control Clin Trials 2003 1.23
42 Effects of disclosing financial interests on attitudes toward clinical research. J Gen Intern Med 2008 1.23
43 Improving informed consent: the medium is not the message. IRB 2004 1.23
44 Controversy and quality improvement: lingering questions about ethics, oversight, and patient safety research. Jt Comm J Qual Patient Saf 2008 1.22
45 Ethical issues in identifying and recruiting participants for familial genetic research. Am J Med Genet A 2004 1.20
46 Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics 2006 1.19
47 An intervention to improve cancer patients' understanding of early-phase clinical trials. IRB 2009 1.18
48 Disclosure of cancer diagnosis and prognosis in Northern Tanzania. Soc Sci Med 2003 1.17
49 Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach. J Med Ethics 2010 1.15
50 Conducting empirical research on informed consent: challenges and questions. IRB 2004 1.14
51 Challenges to effective research in acute trauma resuscitation: consent and endpoints. Shock 2011 1.13
52 Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey. Clin Trials 2012 1.11
53 Reflecting on short-term international service-learning trips. Acad Med 2013 1.08
54 Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear? J Empir Res Hum Res Ethics 2008 1.08
55 Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study. Control Clin Trials 2002 1.08
56 Factors that affect infertility patients' decisions about disposition of frozen embryos. Fertil Steril 2006 1.07
57 Disclosure of financial relationships to participants in clinical research. N Engl J Med 2009 1.06
58 Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion 2008 1.06
59 Ethics, oversight and quality improvement initiatives. Qual Saf Health Care 2010 1.04
60 Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. Circulation 2013 1.04
61 Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genet Test 2002 1.04
62 Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Account Res 2007 1.03
63 Developing model language for disclosing financial interests to potential clinical research participants. IRB 2007 1.03
64 Ethics guidance for HIV prevention trials. BMJ 2003 1.03
65 Position statement on the provision and procurement of human eggs for stem cell research. Cell Stem Cell 2013 1.02
66 India's new policy to protect research participants. BMJ 2013 1.01
67 Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP. Dev World Bioeth 2013 0.96
68 Who refuses enrollment in cardiac clinical trials? Clin Trials 2007 0.96
69 Ethical challenges in international HIV prevention research. Account Res 2004 0.94
70 Determining the costs of Institutional Review Boards. IRB 2007 0.94
71 Consulting communities when patients cannot consent: a multicenter study of community consultation for research in emergency settings. Crit Care Med 2014 0.94
72 Bioethics and professionalism in popular television medical dramas. J Med Ethics 2010 0.94
73 The importance of cultural considerations in the promotion of ethical research with human biologic material. J Lab Clin Med 2005 0.93
74 "Special scrutiny": a targeted form of research protocol review. Ann Intern Med 2004 0.92
75 Confirming comprehension of informed consent as a protection of human subjects. J Gen Intern Med 2006 0.92
76 An ethics curriculum for short-term global health trainees. Global Health 2013 0.91
77 Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. Am Heart J 2008 0.90
78 Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings. J Gen Intern Med 2010 0.89
79 Empirical research on informed consent with the cognitively impaired. IRB 2004 0.89
80 Forecast for the Physician Payment Sunshine Act: partly to mostly cloudy? Ann Intern Med 2014 0.89
81 Quality assurance questionnaire for professionals fails to improve the quality of informed consent. Clin Trials 2007 0.87
82 Ethics in population-based genetic research. Account Res 2004 0.87
83 Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants. Clin Trials 2007 0.86
84 The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions. J Cereb Blood Flow Metab 2008 0.86
85 Missing the informed in consent. Anesth Analg 2003 0.86
86 Educational approaches to the responsible conduct of clinical research: an exploratory study. Acad Med 2007 0.85
87 Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting. Acad Med 2010 0.85
88 Seeking assent and respecting dissent in dementia research. Am J Geriatr Psychiatry 2010 0.85
89 Ethical issues in evidence-based surgery. Surg Clin North Am 2006 0.85
90 Are research subjects adequately protected? A review and discussion of studies conducted by the Advisory Committee on Human Radiation Experiments. Kennedy Inst Ethics J 1996 0.84
91 Determining the appropriateness of including children in clinical research: how thick is the ice? JAMA 2004 0.83
92 Reviewing HIV-Related Research in Emerging Economies: The Role of Government Reviewing Agencies. Dev World Bioeth 2014 0.83
93 Getting the ethics right regarding research in the emergency setting: lessons from the PolyHeme study. Kennedy Inst Ethics J 2007 0.82
94 The ethical review of health care quality improvement initiatives: findings from the field. Issue Brief (Commonw Fund) 2010 0.81
95 The influence of HIV serostatus on physicians' clinical decisions. AIDS Public Policy J 1994 0.80
96 Enhancing communication among data monitoring committees and institutional review boards. Clin Trials 2008 0.80
97 Community consultation for prehospital research: experiences of study coordinators and principal investigators. Prehosp Emerg Care 2014 0.80
98 Ethics in behavioral genetics research. Account Res 2004 0.80
99 Realizing HOPE: The Ethics of Organ Transplantation From HIV-Positive Donors. Ann Intern Med 2016 0.79
100 Community consultation: not the problem--an important part of the solution. Am J Bioeth 2006 0.79
101 Perceptions of a short-term medical programme in the Dominican Republic: voices of care recipients. Glob Public Health 2014 0.79
102 Bioethical considerations in developing a biorepository for the Pneumonia Etiology Research for Child Health project. Clin Infect Dis 2012 0.79
103 Optimizing the protection of research participants and personnel in HIV-related research where TB is prevalent: practical solutions for improving infection control. J Acquir Immune Defic Syndr 2014 0.78
104 Ethics and the standards of prevention in HIV prevention trials. AIDS 2010 0.78
105 Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials. Ann Rheum Dis 2006 0.78
106 Patient and family perspectives on respect and dignity in the intensive care unit. Narrat Inq Bioeth 2015 0.78
107 Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR Tenth Annual Meeting. Cell Stem Cell 2012 0.77
108 Policy recommendations for addressing privacy challenges associated with cell-based research and interventions. BMC Med Ethics 2014 0.77
109 Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058. J Acquir Immune Defic Syndr 2015 0.77
110 Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials. IRB 1998 0.77
111 New ISSCR guidelines: clinical translation of stem cell research. Lancet 2016 0.77
112 Risk in drug trials. Lancet 2006 0.77
113 Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs. IRB 2015 0.75
114 Toward definitive trials and improved outcomes of cardiac arrest. Circulation 2010 0.75
115 Tb in a global health exchange program. J Gen Intern Med 2012 0.75
116 Response to open peer commentaries on "Medical and nursing students' television viewing habits: potential implications for bioethics". Am J Bioeth 2008 0.75
117 Lying, cheating and stealing in clinical research. Clin Trials 2004 0.75
118 Ethics and policy issues for stem cell research and pulmonary medicine. Chest 2015 0.75
119 Clarification, continued. IRB 2013 0.75
120 Guidelines for international service learning programs. Dev World Bioeth 2011 0.75
121 Ethical implications of modifying lethal injection protocols. PLoS Med 2008 0.75
122 Examining the scale and outcomes of global health fellowship programs in the United States. J Grad Med Educ 2012 0.75
123 Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J Med Ethics 2007 0.75
124 Guidelines for global health training. Health Aff (Millwood) 2011 0.75
125 A Clinician's Guide to Privacy and Communication in the ICU. Crit Care Med 2016 0.75
126 HIV cure research: print and online media reporting in Australia. J Virus Erad 2017 0.75
127 How to determine whether existing human embryonic stem cell lines can be used ethically. Cell Stem Cell 2008 0.75
128 Health care professionals' perceptions and experiences of respect and dignity in the intensive care unit. Narrat Inq Bioeth 2015 0.75
129 Who should go first in trials with scarce agents? The views of potential participants. IRB 2007 0.75
130 Observations of respect and dignity in the intensive care unit. Narrat Inq Bioeth 2015 0.75
131 A Direct Observation Checklist to Measure Respect and Dignity in the ICU. Crit Care Med 2017 0.75
132 Measuring patients' experiences of respect and dignity in the intensive care unit: a pilot study. Narrat Inq Bioeth 2015 0.75
133 Ethics and research assessing the relative roles of genes and the environment. Account Res 2005 0.75
134 Comparison of Approaches for Notification and Authorization in Pragmatic Clinical Research Evaluating Commonly Used Medical Practices. Med Care 2017 0.75
135 Of mice and men: skin cells, stem cells and ethical uncertainties. Regen Med 2009 0.75
136 Understanding treatment with respect and dignity in the intensive care unit. Narrat Inq Bioeth 2015 0.75
137 Toward achieving meaningful informed consent in AIDS vaccine trials with injection-drug users. AIDS Public Policy J 1994 0.75
138 Toward treatment with respect and dignity in the intensive care unit. Narrat Inq Bioeth 2015 0.75